Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.39	57.26	80.93	178.27	305.74	233.35
Cash & Short-Term Investments	74.39	57.26	80.93	178.27	305.74	233.35
Cash Growth	-2.38%	-29.24%	-54.60%	-41.69%	31.02%	70.51%
Accounts Receivable	15.64	10.23	15.22	28.21	23.11	23.93
Other Receivables	0.56	0.17	0.17	0.14	0.68	0.74
Receivables	16.2	10.4	15.39	28.35	23.79	24.67
Inventory	12.85	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	6.96	7.11	10.5	9.66	7.07	6.72
Other Current Assets	-	1.17	-	-	-	-
Total Current Assets	110.4	90.37	117.02	230.43	346.46	266.15
Property, Plant & Equipment	15.52	17.12	23.5	33.01	34.07	32.41
Long-Term Investments	-	-	-	-	-	17.57
Other Intangible Assets	29.73	31.86	20.29	27.2	12.55	14.63
Other Long-Term Assets	4.24	4.87	6.72	3.66	3.42	2.66
Total Assets	159.9	144.22	167.53	294.3	396.5	333.41
Accounts Payable	20.19	31.64	34.81	57.24	47.43	11.41
Accrued Expenses	25.89	30.74	34.68	36.51	39.99	31.26
Short-Term Debt	-	-	3.93	5	0.81	-
Current Portion of Long-Term Debt	3.75	0.63	3	7.24	4.51	4.52
Current Portion of Leases	2.14	2.62	2.52	2.45	2.1	1.85
Current Income Taxes Payable	0.98	0.93	0.84	0.72	0.35	0.14
Current Unearned Revenue	-	-	-	-	2.61	-
Other Current Liabilities	4.57	4.84	5.13	18.55	3.24	2.58
Total Current Liabilities	57.52	71.4	84.91	127.72	101.04	51.76
Long-Term Debt	50.03	57.96	60.86	93.14	46.56	59.81
Long-Term Leases	13.3	14.75	18.28	21.57	20.99	22.89
Other Long-Term Liabilities	1.66	1.76	1.89	1.85	2.03	1.95
Total Liabilities	122.51	145.87	165.94	244.28	170.63	136.41
Common Stock	0.03	0.03	0.02	0.01	0.1	0.1
Additional Paid-In Capital	779.86	763.57	717.4	675.94	656.03	583
Retained Earnings	-735.97	-740.87	-694.87	-634.23	-547.46	-482.76
Total Common Equity	43.92	22.73	22.54	41.72	108.67	100.34
Minority Interest	-6.54	-24.38	-20.96	8.3	117.2	96.66
Shareholders' Equity	37.38	-1.64	1.59	50.03	225.88	197
Total Liabilities & Equity	159.9	144.22	167.53	294.3	396.5	333.41
Total Debt	69.22	75.96	88.59	129.4	74.98	89.08
Net Cash (Debt)	5.17	-18.7	-7.67	48.87	230.77	144.28
Net Cash Growth	-	-	-	-78.82%	59.95%	564.37%
Net Cash Per Share	0.20	-0.90	-0.95	8.25	42.37	30.06
Filing Date Shares Outstanding	29.75	29.53	19.23	8.65	6.97	6.33
Total Common Shares Outstanding	29.75	27.91	15.09	7.37	6.76	6.33
Working Capital	52.88	18.97	32.11	102.72	245.42	214.39
Book Value Per Share	1.48	0.81	1.49	5.66	16.07	15.86
Tangible Book Value	14.19	-9.13	2.25	14.52	96.12	85.71
Tangible Book Value Per Share	0.48	-0.33	0.15	1.97	14.21	13.55
Buildings	0.58	0.58	0.58	0.58	0.58	-
Machinery	1.61	1.61	1.61	10.76	8.68	7.61
Construction In Progress	-	-	0.03	0.95	2.03	0.5
Leasehold Improvements	3.29	11	13.18	13.18	13.18	10.58

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q